Simplify Asset Management’s Palisade Bio PALI Stock Holding History

Simplify Asset Management’s Portfolio PALI Stock Details PALI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$942K	Buy	450,543 +100,543	+29%	+$198K	0.01%	87
2026 Q1	$613K	Buy	+350,000	New	+$636K	0.01%	96

Other funds holding PALI

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

NAM

NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Simplify Asset Management's PALI Position: Q2 2026 in Review

Simplify Asset Management increased its Palisade Bio (PALI) stake by 29% in Q2 2026, buying an estimated $198K and bringing the position to 450,543 shares worth $942K. The position accounts for 0.01% of the portfolio, ranked #87.

Simplify Asset Management first reported a position in PALI in Q1 2026 and has held it in 2 quarters since. 4 funds tracked by Wall St. Rank hold PALI as of Q2 2026.

Simplify Asset Management held 450,543 shares of Palisade Bio worth $942K as of Q2 2026.
Simplify Asset Management bought 100,543 Palisade Bio shares in Q2 2026, an estimated $198K.
Palisade Bio made up 0.01% of Simplify Asset Management's portfolio in Q2 2026, its #87 holding.
Simplify Asset Management first reported a position in Palisade Bio in Q1 2026 and has held it in 2 quarters since.
4 funds tracked by Wall St. Rank held Palisade Bio as of Q2 2026.

Based on Simplify Asset Management's 13F filing for Q2 2026, filed 16 Jul 2026.